BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27605378)

  • 1. Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond.
    Chand V; Nandi D; Mangla AG; Sharma P; Nag A
    Open Biol; 2016 Sep; 6(9):. PubMed ID: 27605378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a peptide that disrupts hADA3-E6 interaction with implications in HPV induced cancer therapy.
    Chand V; Kapoor A; Kundu S; Nag A
    Life Sci; 2022 Jan; 288():120157. PubMed ID: 34801511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator.
    Zeng M; Kumar A; Meng G; Gao Q; Dimri G; Wazer D; Band H; Band V
    J Biol Chem; 2002 Nov; 277(47):45611-8. PubMed ID: 12235159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation.
    Chand V; John R; Jaiswal N; Johar SS; Nag A
    Carcinogenesis; 2014 Aug; 35(8):1830-9. PubMed ID: 24795430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation.
    Meng G; Zhao Y; Nag A; Zeng M; Dimri G; Gao Q; Wazer DE; Kumar R; Band H; Band V
    J Biol Chem; 2004 Dec; 279(52):54230-40. PubMed ID: 15496419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.
    Kumar A; Zhao Y; Meng G; Zeng M; Srinivasan S; Delmolino LM; Gao Q; Dimri G; Weber GF; Wazer DE; Band H; Band V
    Mol Cell Biol; 2002 Aug; 22(16):5801-12. PubMed ID: 12138191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells.
    Hu Y; Ye F; Lu W; Hong D; Wan X; Xie X
    Cancer Invest; 2009 Mar; 27(3):298-306. PubMed ID: 19194825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of transcriptional and phosphatase regulators as interaction partners of human ADA3, a component of histone acetyltransferase complexes.
    Zencir S; Sike A; Dobson MJ; Ayaydin F; Boros I; Topcu Z
    Biochem J; 2013 Mar; 450(2):311-20. PubMed ID: 23167988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
    Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
    PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma.
    Thierry F
    Virology; 2009 Feb; 384(2):375-9. PubMed ID: 19064276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing RNA.
    Min W; Wen-li M; Zhao-hui S; Ling L; Bao Z; Wen-ling Z
    Int J Gynecol Cancer; 2009 May; 19(4):547-63. PubMed ID: 19509549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.
    Hoppe-Seyler K; Mändl J; Adrian S; Kuhn BJ; Hoppe-Seyler F
    Viruses; 2017 Jul; 9(7):. PubMed ID: 28678198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
    Ren C; Cheng X; Lu B; Yang G
    Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
    Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
    Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-mediated genome instability: at the roots of cervical carcinogenesis.
    Boccardo E
    Cytogenet Genome Res; 2010; 128(1-3):57-65. PubMed ID: 20389033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.